Discovery of therapeutic antibodies targeting breast cancer metastasis using enabled g-protein-coupled receptors
Ended Cooperative Agreement Awarded Last action
- Award ID
- R43CA213832
- Recipient
-
Abilita Therapeutics Inc. UEI DEYUQFS2MLT5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $300,000
Award facts
- Assistance listing
- 93.396 Cancer Biology Research
- Completion date
- Originally
- Place of performance
- San Diego, CA 92121, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $300,000 |
Quick answers
Who received award R43CA213832?
R43CA213832 was awarded to Abilita Therapeutics Inc. by National Cancer Institute (National Institutes of Health) on September 19, 2016.
How much is award R43CA213832 worth?
$300,000 has been obligated on R43CA213832.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award